Evidence map›Paper›PMID 34898143›Full record

ArticleTrends in psychiatry and psychotherapy2022

Non-medical cannabis use: international policies and outcomes overview. An outline for Portugal.

Pedro Cabral Barata, Filipa Ferreira, Catarina Oliveira

Open access · diamondAbstract read
In one paragraph

Article in Trends in psychiatry and psychotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Current state of the global impact of cannabis use.Trends in psychiatry and psychotherapy · 2022
    Article
  4. Monitoring the impact of cannabis use.Trends in psychiatry and psychotherapy · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Pedro Cabral BarataRegionspsykiatrien Vest, Herning, Denmark.
Filipa FerreiraDepartamento de Psiquiatria e Saúde Mental, Hospital Prof. Dr. Fernando Fonseca, Amadora, Portugal.
Catarina OliveiraDepartamento de Psiquiatria e Saúde Mental, Unidade Local de Saúde de Castelo Branco, Castelo Branco, Portugal.
Hospital Prof. Dr. Fernando Fonseca · PTPolytechnic Institute of Castelo Branco · PTRegional Hospital West Jutland · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCannabis is probably the most commonly used illicit drug. It is often regarded as a relatively nonharmful experience, even though evidence indicates otherwise. Legalization of non-medical cannabis, which has already taken place in several countries, is currently a controversial issue.

objectiveTo provide an up-to-date overview of current models and policies and their outcomes that can inform future political decisions regarding non-medical cannabis use.

methodsPubMed/MEDLINE and Google Scholar scientific databases were searched for articles written in English, Spanish, and Portuguese published between 1990 and December 2020. The reference lists of these articles were similarly used as bibliography sources. Gray literature was also included.

resultsWhile non-medical cannabis has been decriminalized in many countries, it has only been legalized in Uruguay, Canada, and some U.S. states. Several benefits of legalization were identified: decreases in cannabis-related crimes, law-enforcement and judicial costs; reduction in synthetic cannabis supply; decline in black economies and possible diminution of other illegal drug buying; and tax revenue increases. Reported legalization problems included: increases in cannabis use; cannabis-related disorders; and cannabis-related accidents and hospitalizations. Harm-reduction strategies are available in the scientific literature.

conclusionGrowing, although incomplete, evidence exists to guide policy makers, minimize cannabis-related harm, and positively contribute to public health, if the legalization path is to be followed. Dialogue between legislators and science should be encouraged. There are more than a few legalization pathways, with diverse economic, social and health wellbeing effects. Public health-driven, instead of profit-driven models, seem to offer the most benefits regarding non-medical cannabis legalization. Most of the true public health effects of cannabis legalization are still unknown, for we are still in the early stages of these policies and their implications. Future studies should address the medium-to-long-term social, economic, and health consequences of legalization policies.

Indexed as

CannabisHumansLegislation, DrugPortugalPublic HealthPublic Policycannabis decriminalization:Cannabis legalizationnon-medical cannabisPortugal

Identifiers

PMID34898143
PMCPMC9490937
OpenAlexW3203291854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.